Skip to main content Accessibility help
×
Home
Hostname: page-component-65dc7cd545-nrv4r Total loading time: 1.675 Render date: 2021-07-26T02:28:12.055Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive–compulsive disorder: proton magnetic resonance spectroscopy

Published online by Cambridge University Press:  17 October 2016

Shin-Eui Park
Affiliation:
Interdisciplinary Program of Biomedical Engineering, Chonnam National University, Gwangju, Republic of Korea
Nam-Gil Choi
Affiliation:
Department of Radiology, DongShin University, Naju, Republic of Korea
Gwang-Woo Jeong
Affiliation:
Interdisciplinary Program of Biomedical Engineering, Chonnam National University, Gwangju, Republic of Korea Department of Radiology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea
Corresponding
E-mail address:

Abstract

Objective

Proton magnetic resonance spectroscopy (1H-MRS) was used to evaluate metabolic changes in the dorsolateral prefrontal cortex (DLPFC) in patients with obsessive–compulsive disorder (OCD).

Methods

In total, 14 OCD patients (mean age 28.9±7.2 years) and 14 healthy controls (mean age 32.6±7.1 years) with no history of neurological and psychiatric illness participated in this study. Brain metabolite concentrations were measured from a localised voxel on the right DLPFC using a 3-Tesla 1H-MRS.

Results

The metabolic concentration of myo-inositol in patients with OCD increased significantly by 52% compared with the healthy controls, whereas glutamine/glutamate was decreased by 11%. However, there were no significant differences in N-acetylaspartate, choline, lactate and lipid between the two groups.

Conclusion

These findings would be helpful to understand the pathophysiology of OCD associated with the brain metabolic abnormalities in the right DLPFC.

Type
Original Articles
Copyright
© Scandinavian College of Neuropsychopharmacology 2016 

Access options

Get access to the full version of this content by using one of the access options below.

References

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (text revision), 5th edn. Washington, DC: American Psychiatric Association, 2013.Google Scholar
2. Karno, M, Golding, JM, Sorenson, SB et al. The epidemiology of obsessive compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:10941099.CrossRefGoogle Scholar
3. Zohar, J, Chopra, M, Sasson, Y et al. Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 2000;1:92100.CrossRefGoogle Scholar
4. Greist, JH, Jefferson, JW, Kobak, KA et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 1995;52:5360.CrossRefGoogle ScholarPubMed
5. Russell, A, Cortese, B, Lorch, E et al. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2003;13(Suppl. 1):s31s38.CrossRefGoogle ScholarPubMed
6. Ebert, D, Speck, O, König, A et al. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997;74:173176.CrossRefGoogle ScholarPubMed
7. Bartha, R, Stein, MB, Williamson, PC et al. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998;155:15841591.CrossRefGoogle Scholar
8. Simpson, HB, Shungu, DC, Bender, J Jr. et al. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology 2012;37:26842692.CrossRefGoogle Scholar
9. Simpson, HB, Kegeles, LS, Hunter, L et al. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy. Psychiatry Res 2015;232:6570.CrossRefGoogle Scholar
10. Rosenberg, DR, MacMaster, FP, Keshavan, MS et al. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000;39:10961103.CrossRefGoogle ScholarPubMed
11. Ohara, K, Isoda, H, Suzuki, Y et al. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res 1999;92:8391.CrossRefGoogle ScholarPubMed
12. den Braber, A, van ‘t Ent, D, Cath, DC et al. Brain activation during cognitive planning in twins discordant or concordant for obsessive-compulsive symptoms. Brain 2010;133:31233140.CrossRefGoogle ScholarPubMed
13. Togao, O, Yoshiura, T, Nakao, T et al. Regional gray and white matter volume abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Psychiatry Res 2010;184:2937.CrossRefGoogle ScholarPubMed
14. Sachdev, PS, McBride, R, Loo, CK et al. Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. J Clin Psychiatry 2001;62:981984.CrossRefGoogle ScholarPubMed
15. Alvarenga, PG, do Rosário, MC, Batistuzzo, MC et al. Obsessive-compulsive symptom dimensions correlate to specific gray matter volumes in treatment-naïve patients. J Psychiatr Res 2012;46:16351642.CrossRefGoogle ScholarPubMed
16. Goodman, WK, Price, LH, Rasmussen, SA et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 1989;46:10121016.CrossRefGoogle ScholarPubMed
17. Reyngoudt, H, Claeys, T, Vlerick, L et al. Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study. Eur J Radiol 2012;81:e223e231.CrossRefGoogle Scholar
18. Milad, MR, Rauch, SL. Obsessive compulsive disorder: beyond segregated cortico striatal pathway. Trends Cogn Sci 2012;16:4351.CrossRefGoogle Scholar
19. Ting, JT, Feng, G. Glutamatergic synaptic dysfunction and obsessive-compulsive disorder. Curr Chem Genomics 2008;2:6275.CrossRefGoogle Scholar
20. Whiteside, SP, Port, JD, Deacon, BJ et al. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 2006;146:137147.CrossRefGoogle ScholarPubMed
21. Rosenberg, DR, Mirza, Y, Russell, A et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 2004;43:11461153.CrossRefGoogle ScholarPubMed
22. Rosenberg, DR, Keshavan, MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 1998;43:623640.CrossRefGoogle Scholar
23. Szeszko, PR, MacMillan, S, McMeniman, M et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 2004;161:10491056.CrossRefGoogle Scholar
24. Keshavan, MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 1999;33:513521.CrossRefGoogle ScholarPubMed
25. Kim, H, McGrath, BM, Silverstone, PH. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders-focus on magnetic resonance spectroscopy (MRS) studies. Hum Psychopharmacol 2005;20:309326.CrossRefGoogle ScholarPubMed
26. Vaden, DL, Ding, D, Peterson, B et al. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J Biol Chem 2001;27:1546615471.CrossRefGoogle Scholar
27. Chang, L, Ernst, T, Grob, CS et al. Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) users. J Magn Reson Imaging 1999;10:521526.3.0.CO;2-9>CrossRefGoogle Scholar
8
Cited by

Linked content

Please note a has been issued for this article.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive–compulsive disorder: proton magnetic resonance spectroscopy
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive–compulsive disorder: proton magnetic resonance spectroscopy
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive–compulsive disorder: proton magnetic resonance spectroscopy
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *